未登录

D

Douglas Osei-Hyiaman

national institutes of health (nih) - usa

H指数:35

被引数:6,769

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2020-12-1411

OAAI

Plasma metabolome analysis of patients with major depressive disorder

抑郁症患者血浆代谢组学分析

PSYCHIATRY AND CLINICAL NEUROSCIENCES

IF6.2

2018-03-0351

OAAI

Mice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissue

SCIENTIFIC REPORTS

IF3.9

2015-10-1228

OAAI

Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences

CELL AND BIOSCIENCE

IF6.2

2015-05-3031

OAAI

Dietary Linoleic Acid Elevates Endogenous 2-AG and Anandamide and Induces Obesity

IF4.7

2012-10-17201

OAAI

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity (vol 120, pg 2953, 2010)

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2010-10-012

OA

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2010-08-02421

OA

Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-γ

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2010-06-0187

OAAI

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid ω-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

IF3.1

2010-03-16108

OAAI

Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?

TRENDS IN PHARMACOLOGICAL SCIENCES

IF19.9

2009-01-01138

OAAI

The Endogenous Brain Constituent N-Arachidonoyl L-Serine Is an Activator of Large Conductance Ca2+-Activated K+ Channels

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2009-01-0138

OAAI

Endocannabinoids and the Control of Energy Homeostasis

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2008-11-0189

OAAI

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2008-09-02411

OA

Sustained weight loss after roux-en-y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function

ANNALS OF SURGERY

IF6.4

2008-05-0147

OAAI

Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

IF3.3

2008-05-0140

PREAI

Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury

GASTROENTEROLOGY

IF25.1

2008-04-01172

OA

Pivotal Advance:: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

JOURNAL OF LEUKOCYTE BIOLOGY

IF3.1

2007-07-25137

OAAI

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

Cannabinoid-2受体介导肝脏缺血/再灌注损伤的保护作用

IF4.2

2007-02-27246

OAAI

A biosynthetic pathway for anandamide

anandamide的生物合成途径

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2006-09-05431

OAAI

Glutathione-S-transferase expression in the brain:: possible role in ethanol preference and longevity

IF4.2

2006-09-0137

PREAI